Clinical Trial Update: China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population [NA]

View source ↗

Summary

Clinical trial update reporting safety and effectiveness results of Edwards Lifesciences' SAPIEN 3 transcatheter heart valve in the Chinese population with aort…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Regurgitation
• Aortic Stenosis

Drugs mentioned

• SAPIEN 3 Transcatheter Heart Valve (transcatheter heart valve)

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Stenosis, Symptomatic Aortic Stenosis | NA | Status: COMPLETED | Results posted: 2020-07-15